First Sabrepoint Capital Management’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-250,000
Closed -$6.42M 38
2025
Q4
$6.42M Sell
250,000
-100,000
-29% -$2.3M 2.48% 17
2025
Q3
$7.53M Buy
350,000
+120,000
+52% +$2.73M 2.38% 15
2025
Q2
$5.06M Sell
230,000
-130,000
-36% -$2.85M 1.8% 17
2025
Q1
$8.04M Sell
360,000
-200,000
-36% -$4.31M 2.98% 14
2024
Q4
$9.66M Buy
+560,000
New +$8.69M 2.59% 13
2021
Q3
Sell
-40,000
Closed -$2.36M 34
2021
Q2
$2.36M Sell
40,000
-95,000
-70% -$5.34M 0.74% 27
2021
Q1
$6.01M Sell
135,000
-35,000
-21% -$1.64M 1.95% 25
2020
Q4
$7.21M Sell
170,000
-230,000
-58% -$7.48M 2.32% 24
2020
Q3
$11.8M Buy
+400,000
New +$11M 4.2% 9

Other funds holding PGNY

First Sabrepoint Capital Management's PGNY Position: Q1 2026 in Review

First Sabrepoint Capital Management sold out of Progyny (PGNY) in Q1 2026, closing a stake of 250,000 shares — an estimated $6.42M sold.

First Sabrepoint Capital Management first reported a position in PGNY in Q3 2020 and held it in 9 quarters. The position peaked at $11.8M in Q3 2020. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • First Sabrepoint Capital Management reported no remaining Progyny position as of Q1 2026 after selling out during the quarter.
  • First Sabrepoint Capital Management sold 250,000 Progyny shares in Q1 2026, an estimated $6.42M.
  • First Sabrepoint Capital Management first reported a position in Progyny in Q3 2020 and held it in 9 quarters.
  • First Sabrepoint Capital Management's Progyny position peaked at $11.8M in Q3 2020.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on First Sabrepoint Capital Management's 13F filing for Q1 2026, filed 15 May 2026.